• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Papilloma

Papilloma - 91 Studies Found

Completed : Human Papillomavirus 6/11 in the Lower Airway of Neonates
: Papillomavirus Infections
: 2007-10-24
Completed : An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)
: Papillomavirus Infections
: 2007-07-03
:
  • Biological: Quadrivalent Human Papillomavirus (HPV, Types 6, 11, 16, 18) Rec

Completed : Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)
: Papillomavirus Infections
: 2006-09-22
: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine Quadrivalent HPV
Completed : Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)
: Papillomavirus Infections
: 2005-09-07
:
  • Biological: Gardasil™ Ga

Completed : The Human Papillomavirus (HPV) Transmission Pilot Study
: Human Papillomavirus Infection
: 2009-01-13
Completed : A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection
: Human Papillomavirus Infection
: 2016-05-17
: Device: Vaginal swab Vaginal cell collection will be performed with the two types of indicated swab.
Completed : An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women
: Human Papillomavirus Infection
: 2015-06-03
:
  • Behavioral: IMB Intervention Group

Active, not recruiting : A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
: Human Papillomavirus Infection
: 2013-11-08
: Biological: V503 (9-valent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] vaccine) V503, a 9-va
Completed : Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine
: Human Papillomavirus Infection
: 2012-09-27
: Other: Prevalence-based model Static prevalence-based model to estimate vaccine effect over a one-year p
Completed : Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System
: Human Papillomavirus Infection
: 2012-09-24
: Device: APTIMA HPV Assay In Vitro Diagnostics Assay
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.